Skip to main content

Why the new junior doctor contract is bad for academic medicine and the UK's economy

As a clinician and academic, I was deeply saddened to see the Secretary of State for Health impose a new contract on junior doctors. The 55,000 junior doctors in England’s NHS are perhaps the most intelligent and highly educated and trained professional group in the country. They are perfectly capable of looking at the contractual changes being put forward by the NHS and drawing their own conclusions about the implications of the new contract for them. To say that they have been ‘brainwashed’ by extremist members of the British Medical Association, as some journalists and Conservative MPs have been implying, is ludicrous.

We also continue to hear from the Secretary of State for Health, Jeremy Hunt, that he believes that these contractual changes are needed to tackle higher weekend mortality in hospitals. This is an area in which I have and members of my department have published extensively. I am therefore fully aware of the research on this topic and the serious problems with some of the statements issued by Jeremy Hunt and the Department of Health (for example, see The UK Statistics Authority has written to the Department of Health about this matter but this letter does not seem to have had any effect on Jeremy Hunt or his officials.

Through my clinical and academic work, I am in regular contact with many junior doctors. They are becoming increasingly disillusioned and anxious about their future. Many are considering leaving the NHS to work overseas in countries such as Australia, New Zealand or Canada. Others are considering giving up their medical careers. The UK cannot afford to lose such highly trained professionals. As well as being essential for the NHS and the delivery of healthcare in England, junior doctors are also the clinical academics and medical scientists of the future. Healthcare-related industries such as pharmaceuticals are one of the few areas where the UK is still a world-leader. The future prosperity of these industries - and the economy of the UK - will be threatened by the loss of so many highly talented professionals.


Popular posts from this blog

Improving how secondary care and general practice in England work together: the NHS Standard Contract

Due to the increasing pressures on general practices within the National Health Service in England, the interface between primary and secondary care, and the division of labour between these, has become an important issue. This has long been an area prone to difficulties and conflict, the consequences of which can directly impact the quality and safety of patient care, particularly for patients with chronic conditions who regularly transition between these two sectors. In an article published in the Journal of the Royal Society of Medicine, Amy Price and I explore the measures recently implemented in the NHS Standard Contract which aim to target common issues at the primary–secondary care interface, with an aim to reducing inappropriate general practitioner workload in England. We discuss the context behind the implementation of the NHS Standard Contract as well as current concerns and areas for further consideration.

The current crisis in primary care means the NHS Standard Contract…

Patients are more satisfied with general practices managed by GP partners than those managed by companies

General practices in England are independent businesses that are contracted to provide primary care for specified populations. Most are owned by general practitioners, but many types of organisation are now eligible to deliver these services. In a study published in the Journal of the Royal Society of Medicine, we examined the association between patient experience and the contract type of general practices in England, distinguishing limited companies from other practices.

We analysed data from the English General Practice Patient Survey 2013–2014 (July to September 2013 and January to March 2014). Patients were eligible for inclusion in the survey if they had a valid National Health Service number, had been registered with a general practice for six months or more, and were aged 18 years or over. All general practices in England with eligible patients were included in the survey (n = 8017).

Patients registered to general practices owned by limited companies reported worse experience…

Dr Demis Hassabis, Co-Founder and CEO of DeepMind, Speaks about AI in Healthcare

On 28 September 2017, I attended the Annual Institute of Global Health Innovation Lecture: Artificial General Intelligence and Healthcare, delivered by Dr Demis Hassabis, co-founder and CEO of Google DeepMind. Artificial intelligence is the science of making machines smart argued Dr Hassabis, so how can we make it improve the healthcare sector? Dr Hassabis then went on to describe the work that DeepMind was carrying out in healthcare in areas such as organising information, deep learning to support the reporting of medical images (such as scans and pathology slides), and biomedical science. Dr Hassabis also discussed the challenges of applying techniques such as reinforcement learning in healthcare. He concluded that artificial intelligence has great scope for improving healthcare; for example, by prioritising the tasks that clinicians had to carry out and by providing decision support aids for both patients and doctors. Dr Hassabis also discussed some of the ethical issues in using …